P 37
Latest Information Update: 01 Feb 2000
At a glance
- Originator Phytopharm
- Class Antipsoriatics
- Mechanism of Action Keratinocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 01 Feb 2000 Discontinued-Preclinical for Psoriasis in United Kingdom (Topical)
- 19 Nov 1999 P 37 is available for licensing (http://www.phytopharm.co.uk)
- 15 Jan 1998 New profile